Unc-51 Like Kinase 2 (C. Elegans) (ULK2) (internal part) Antikörper

Antigen: Unc-51 Like Kinase 2 (C. Elegans) (ULK2)

Synonyme: ULK2, MGC160050, Unc51.2, AU015340, mKIAA0623, A830085I22Rik

Epitope: internal part

Klonalität: Polyklonal

Wirt: Kaninchen

Applikation: Immunhistochemie (IHC), Western Blot (WB)

Produktnummer: ABIN351316

Produktbeschreibung

Weitere Bezeichnung: ULK2 (internal part)

Swiss-Prot: Q8IYT8

Immunogen: A synthetic peptide from the internal part of human ULK2 conjugated to immunogenic carrier protein has been used as the immunogen. The antigen is homologous in rat and mouse.

Format: Lyophilized

Beschreibung: Catalytic activity: ATP + a protein = ADP + a phosphoprotein. Post-translational modification: Autophosphorylated Also known as: Unc-51-like kinase 2, Serine/threonine-protein kinase ULK2.

Spezifität: Appears to be specific for ULK2.

Anwendungen

Applikationshinweise: IHC, WB. Use at a dilution of 1 : 200 to 1 : 2000. The optimal dilution should be determined by the end user. Not yet tested in other applications.

Reinheit: whole serum

Lagerung: Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Forschungsgebiet: Autophagie

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Ishikawa, Nagase, Suyama et al.: "Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." in: DNA research : an international journal for rapid publication of reports on genes and genomes, Vol. 5, Issue 3, pp. 169-76, 1998 (PubMed).

Greenman, Stephens, Smith et al.: "Patterns of somatic mutation in human cancer genomes." in: Nature, Vol. 446, Issue 7132, pp. 153-8, 2007 (PubMed).